Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC.
about
Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.Genomic Profiling on an Unselected Solid Tumor Population Reveals a Highly Mutated Wnt/β-Catenin Pathway Associated with Oncogenic EGFR Mutations.
P2860
Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Acquisition of EGFR TKI resist ...... pathway in EGFR-mutant NSCLC.
@en
Acquisition of EGFR TKI resist ...... pathway in EGFR-mutant NSCLC.
@nl
type
label
Acquisition of EGFR TKI resist ...... pathway in EGFR-mutant NSCLC.
@en
Acquisition of EGFR TKI resist ...... pathway in EGFR-mutant NSCLC.
@nl
prefLabel
Acquisition of EGFR TKI resist ...... pathway in EGFR-mutant NSCLC.
@en
Acquisition of EGFR TKI resist ...... pathway in EGFR-mutant NSCLC.
@nl
P2093
P2860
P356
P1433
P1476
Acquisition of EGFR TKI resist ...... pathway in EGFR-mutant NSCLC.
@en
P2093
Dacheng Lv
Hongzhuan Chen
Jinnan Yue
Qingnan Zhao
Xiajing Gu
P2860
P304
92240-92253
P356
10.18632/ONCOTARGET.21170
P407
P577
2017-09-21T00:00:00Z